Chlamydia pneumoniae and chronic diseases with a great impact on public health

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 4, 2008, Pages 1041-1043

  Sessa, R ^a   Cipriani, P ^a   di Pietro, M ^a   Schiavoni, G ^a   Santino, Iolanda ^a   del Piano, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

C. pneumoniae; Chronic diseases; Persistent infection

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BACTERIAL SURVIVAL; CELL INTERACTION; CELL SURVIVAL; CELL TYPE; CELLULAR IMMUNITY; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EXTRAPULMONARY CHRONIC DISEASE; HUMAN; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; OXIDATION REDUCTION STATE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PUBLIC HEALTH; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE;

EID: 59849095552     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100431     Document Type: Article

References (14)

1. Sessa R, Schiavoni G, Borriello G, Zagaglia C, Marinelli F, del Piano M, Pozzilli C. Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis. J Neurol 2007; 254:1293-95.
2. Stratton CW, Sriram S. Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect 2003; 5:1249-53.
3. Sessa R, Di Pietro M, Santino I, del Piano M, Varveri A, Dagianti A, Penco M. Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am Heart J 1999; 137:1116-9.
4. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 2002; 5:1-20.
5. Sessa R, Di Pietro M, Schiavoni G, et al. Chlamydia pneumoniae in asymptomatic carotid atherosclerosis. Int J Immunopathol Pharmacol 2006; 19:111-18.
6. Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 2006; 12:397-411.
7. Boelen E, Steinbusch HW, van der Ven AJ, Grauls G, Bruggeman CA, Stassen FR. Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol Aging 2007; 28:524-32.
8. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004; 72:1843-55.
9. de Kruif MD, van Gorp EC, Keller TT, Ossewaarde JM, ten Cate H. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Res 2005; 65:317-27.
10. Wiedeman JA, Kaul R, Heuer LS, Thao NN, Pinkerton KE, Wenman WM. Tobacco smoke induces a persistent, but recoverable state in Chlamydia pneumoniae infection of human endothelial cells. Microb Pathog 2005; 39:197-204.
11. Sessa R, Di Pietro M, Schiavoni G, et al. Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease Atherosclerosis 2001; 159: 521-25.
12. Sessa R, Di Pietro M, Schiavoni G, et al. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J Vasc Surg 2003; 37: 1027-31.
13. Sessa R, Di Pietro M, Schiavoni G, et al.. Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 2007; 195:e224-30.
14. Jendro MC, Deutsch T, Körber B, et al. Infection of human monocyte-derived macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential mechanism for persistent infection. Infect Immun 2000; 68:6704-11.